3.23
Drug Elimination: Non-Renal Routes
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involv…
The liver helps eliminate drugs and metabolites through biliary excretion.
The hepatocytes of the liver secrete bile, into which various transporters actively discharge polar drugs or hydrophilic drug metabolites.
The bile carries the drugs and metabolites into the small intestine, eventually eliminating them through feces.
Sometimes, the parent drug or the drug derived from hydrolysis of metabolites by gut microflora is reabsorbed from the intestine and carried to the liver for re-secretion via bile into the intestine. This cycle is known as enterohepatic circulation.
Such recirculation of drugs often prolongs drug action. While this is sometimes important, it increases the chances of drug toxicity.
Other drug excretion modes include breast milk, lungs, and saliva.
Drugs excreted through breast milk have undesirable effects on suckling infants.
Drugs eliminated through the lungs are mainly different types of anesthetic gases, while drugs excreted through saliva are generally lipophilic and nonionized. Such drugs diffuse through the epithelial cells of the salivary gland.
View the full transcript and gain access to JoVE Core videos
Q1: How does the liver eliminate drugs through biliary excretion?
Hepatocytes in the liver secrete bile containing active transporters that discharge polar drugs and hydrophilic drug metabolites. The bile carries these substances into the small intestine, where they are eventually eliminated through feces. This process is a primary non-renal route for drug elimination and helps reduce systemic drug levels.
Q2: What is enterohepatic circulation and why does it matter?
Enterohepatic circulation occurs when drugs or metabolites are reabsorbed from the intestine and transported back to the liver for re-secretion via bile. This recycling prolongs drug action but increases toxicity risk. Understanding this cycle is important for predicting drug duration and managing potential adverse effects in patients.
Q3: Which drugs are eliminated through the lungs and saliva?
Anesthetic gases are primarily eliminated through the lungs via exhalation. Lipophilic and nonionized drugs are excreted through saliva by diffusing across epithelial cells of the salivary gland. These routes represent alternative elimination pathways when renal and hepatic clearance are insufficient or when drug properties favor pulmonary or salivary excretion.
Q4: Why is breast milk excretion of drugs a clinical concern?
Drugs excreted through breast milk can transfer to suckling infants, causing undesirable or harmful effects. Nursing mothers taking certain medications may expose their infants to drug exposure during a critical developmental period. Healthcare providers must evaluate drug safety profiles and consider alternatives when prescribing to lactating women.
Q5: What role do gut microflora play in drug elimination?
Gut microflora hydrolyze drug metabolites in the intestine, regenerating parent drugs that may be reabsorbed and returned to the liver. This microbial metabolism can influence drug bioavailability and enterohepatic circulation patterns. Antibiotic use disrupting normal microflora can alter expected drug elimination and therapeutic outcomes.
Q6: How do transporters facilitate biliary drug excretion?
Active transporters in hepatocyte membranes actively discharge polar and hydrophilic drugs into bile against concentration gradients. These carrier-mediated processes require energy and are selective for specific drug structures. Transporter function directly determines biliary clearance rates and influences overall drug elimination when renal routes are compromised.
Q7: How do drug properties affect non-renal elimination routes?
Drug lipophilicity and ionization determine excretion pathways. Lipophilic, nonionized drugs readily diffuse through salivary gland epithelium and are excreted in saliva. Polar and hydrophilic drugs require active transporters for biliary excretion. These physicochemical properties predict which non-renal elimination route predominates and influence factors influencing bioavailability.